News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CRO ShangPharma Plans $90 Million IPO on the NYSE


10/4/2010 2:57:40 PM

October 4, 2010 -- ShangPharma Corp., the Shanghai-based CRO, announced plans to stage a $90 million IPO on the New York Stock Exchange. Founded in 2003, the company is one of the largest CROs in China with a staff of more than 1,600 scientists. One of its six divisions, Shanghai ChemPartner, is devoted exclusively to projects from Eli Lilly Company. More details....

Read at BioSpace.com
Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES